Combination treatment of ocular inflammatory disorders and diseases
US11129823B2 · kind B2 · utility
12Cited by
51References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 9, 2017 |
| Grant date | Sep 28, 2021 |
| Priority date | — |
| Expiry date | May 9, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P29/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides a combination of a fused bicyclic amine compound and an anti-inflammatory agent for treating ocular inflammatory disorders and diseases. Further provided are pharmaceutical compositions of the compound and the anti-inflammatory agent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.